Journal
ANNUAL REVIEW OF MEDICINE, VOL 69
Volume 69, Issue -, Pages 319-331Publisher
ANNUAL REVIEWS
DOI: 10.1146/annurev-med-062016-050343
Keywords
genome-driven oncology; precision medicine; basket study; basket trial; knowledgebase
Categories
Funding
- NCI NIH HHS [R25 CA020449, T32 CA009207] Funding Source: Medline
Ask authors/readers for more resources
Understanding a tumor's detailed molecular profile has become increasingly necessary to deliver the standard of care for patients with advanced cancer. Innovations in both tumor genomic sequencing technology and the development of drugs that target molecular alterations have fueled recent gains in genome-driven oncology care. Basket studies, or histology-agnostic clinical trials in genomically selected patients, represent one important research tool to continue making progress in this field. We review key aspects of genome-driven oncology care, including the purpose and utility of basket studies, biostatistical considerations in trial design, genomic knowledgebase development, and patient matching and enrollment models, which are critical for translating our genomic knowledge into clinically meaningful outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available